Literature DB >> 9368174

Reduced intraocular pressure after phacoemulsification and posterior chamber intraocular lens implantation.

C E Jahn.   

Abstract

PURPOSE: To ascertain whether phacoemulsification with posterior chamber intraocular lens (IOL) implantation causes long-term reduction in intraocular pressure (IOP).
SETTING: Private practice, Kempten, Germany.
METHODS: Intraocular pressure was measured in both eyes of 120 consecutive patients who were unilaterally phakic after phacoemulsification a mean of 17 months +/- 17 (SD) previously. Mean age of the 36 men and 84 women was 76 +/- 10 years. Data were analyzed using binomial distribution and the Wilcoxon signed-rank test.
RESULTS: The median ratio of IOP in the pseudophakic eye to IOP in the phakic eye was 0.83. The IOP was lower in the pseudophakic eye in 96 patients (80%). The median IOP was 12 mm Hg in the pseudophakic eyes and 14 mm Hg in the phakic eyes (P < .001). As measured by the interquartile range, IOP distribution was more centered in the pseudophakic than in the phakic eyes (3 versus 4). The IOP in the pseudophakic eyes remained lower to the last measurement, 5 years postoperatively, and appeared to be independent of patient age. Lower IOP in the pseudophakic eye was consistently present in patients with higher IOP in the phakic eye (16 to 22 mm Hg).
CONCLUSION: Phacoemulsification with posterior chamber IOL implantation reduced IOP in most but not all patients with a preoperative IOP of 22 mm Hg or less. This reduction was maintained over several years, with the cause yet to be established. Lower IOP may decrease the risk of subsequent glaucomatous nerve damage in these patients.

Entities:  

Mesh:

Year:  1997        PMID: 9368174     DOI: 10.1016/s0886-3350(97)80325-2

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  14 in total

1.  Clear lens extraction in angle-closure glaucoma patients.

Authors:  Diego T Q Barbosa; Ashleigh L Levison; Shan C Lin
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

2.  Primary lens extraction for glaucoma management: A review article.

Authors:  Tarek M Eid
Journal:  Saudi J Ophthalmol       Date:  2011-07-30

3.  Long-term intraocular pressure changes after combined phacoemulsification, intraocular lens implantation, and vitrectomy.

Authors:  Yuya Ki-I; Takehiro Yamashita; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2012-10-27       Impact factor: 2.447

4.  [Effect of combined cataract surgery and canaloplasty on postoperative intraocular pressure (IOP)].

Authors:  C Gesser; M Matthaei; B Meyer-Rüsenberg; G Richard; M Klemm
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

5.  Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study.

Authors:  Steven L Mansberger; Mae O Gordon; Henry Jampel; Anjali Bhorade; James D Brandt; Brad Wilson; Michael A Kass
Journal:  Ophthalmology       Date:  2012-05-16       Impact factor: 12.079

6.  Effect of cataract extraction and posterior chamber lens implantation on outflow facility and its response to pilocarpine in Korean subjects.

Authors:  C Kee; S H Moon
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

7.  Cataract surgery to lower intraocular pressure.

Authors:  John P Berdahl
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

8.  Effect of intraoperative factors on IOP reduction after phacoemulsification.

Authors:  Eva DeVience; Sona Chaudhry; Osamah J Saeedi
Journal:  Int Ophthalmol       Date:  2016-04-09       Impact factor: 2.031

9.  Risk of hypotony in noninfectious uveitis.

Authors:  Ebenezer Daniel; Maxwell Pistilli; Siddharth S Pujari; R Oktay Kaçmaz; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; John H Kempen
Journal:  Ophthalmology       Date:  2012-07-13       Impact factor: 12.079

10.  Cataract Surgery Lowers Intraocular Pressure and Medication Use in the Medication Group of the Ocular Hypertension Treatment Study.

Authors:  Steven L Mansberger; Stuart K Gardiner; Mae Gordon; Michael Kass; Pradeep Ramulu
Journal:  Am J Ophthalmol       Date:  2021-07-17       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.